Free
Pain Medicine  |   June 2000
Pentobarbital, but not Propofol, Suppresses Vasopressin-stimulated Heat Shock Protein 27 Induction in Aortic Smooth Muscle Cells
Author Affiliations & Notes
  • Osamu Kozawa, M.D., Ph.D.
    *
  • Kumiko Tanabe, M.D., Ph.D.
  • Hiroyuki Matsuno, Ph.D.
  • Masayuki Niwa, Ph.D.
  • Takuji Yamamoto, M.D.
  • Shigeru Akamatsu, M.D., Ph.D.
    §
  • Kanefusa Kato, M.D., Ph.D.
  • Shuji Dohi, M.D., Ph.D.
    #
  • Toshihiko Uematsu, M.D., Ph.D.
    **
  • *Associate Professor, Department of Pharmacology, Gifu University School of Medicine, Gifu, Japan. †Research Fellow, Departments of Pharmacology and Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, Gifu, Japan. ‡Assistant Professor, Department of Pharmacology, Gifu University School of Medicine, Gifu, Japan. §Assistant Professor, Department of Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, Gifu, Japan. ∥Vice President, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Japan. #Professor and Chair, Department of Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, Gifu, Japan. **Professor and Chair, Department of Pharmacology, Gifu University School of Medicine, Gifu, Japan.
Article Information
Pain Medicine
Pain Medicine   |   June 2000
Pentobarbital, but not Propofol, Suppresses Vasopressin-stimulated Heat Shock Protein 27 Induction in Aortic Smooth Muscle Cells
Anesthesiology 6 2000, Vol.92, 1807-1813. doi:
Anesthesiology 6 2000, Vol.92, 1807-1813. doi:
PENTOBARBITAL and propofol reduce systemic blood pressure after intravenous administration. 1–3 It has been shown that these anesthetics have direct and indirect effects on the cardiovascular system. 2,3 These anesthetics have been reported to depress systemic blood pressure via  a redistribution of blood volume through the decrease of systemic vascular resistance. 2,3 In addition, it has been shown that the suppression of myocardial contractility is correlated with the reduction of systemic blood pressure. 2,4,5 However, the exact mechanisms behind the effects of these anesthetics on the cardiovascular system have not yet been fully clarified.
Vascular smooth muscle cells play important roles in the regulation of vascular tone and in atherosclerosis. 6 Vasopressin is a potent vasoactive agent that has been reported to bind to V1receptors in vascular smooth muscle cells. 7 Vasopressin induces phosphoinositide hydrolysis by phospholipase C and phosphatidylcholine hydrolysis by phospholipase D in vascular smooth muscle cells. 7–9 It has been shown that phosphatidylcholine breakdown occurs downstream from phosphoinositide hydrolysis by phospholipase C in a vascular smooth muscle cell line, A10 cells. 8 Both of these types of hydrolysis form diacylglycerol, which is a physiologic activator of protein kinase C. 10 It is well recognized that the activation of protein kinase C plays important roles in signal transduction after vasopressin binding in vascular smooth muscle cells. 11 
Diverse stresses (such as exposure to heat or chemicals) produce heat shock proteins (HSPs) in cells. 12,13 In addition, several HSPs are expressed constitutively in unstressed cells, where they may perform essential functions. 13,14 There are high- and low-molecular-weight HSPs. 14 High-molecular-weight HSPs such as HSP70 and HSP90 are well known to act as molecular chaperones implicated in protein folding and oligomelization. 15,16 Low-molecular-weight HSPs with molecular masses of 15–30 kd, such as HSP27 and αB-crystallin, have significant similarities in terms of amino acid sequences. 17,18 In previous studies, 19,20 we have shown that HSP27 and αB-crystallin are present in various tissues and cells, especially in skeletal and smooth muscle cells. It is recognized that low-molecular-weight HSPs may also act as chaperone proteins. 14,21 Among low-molecular-weight HSPs, evidence is accumulating that HSP27 participates in several functions in a variety of cells types, such as modification of growth in epidermal cells, 22 regulation of apoptosis in murine fibrosarcoma cells, 23 secretion of granules in human platelets, 24 and contraction of vascular smooth muscle cells. 25,26 These observations suggest that HSP27 may play important roles in a variety of physiologic cellular functions. We previously reported that vasopressin stimulates the induction of HSP27 through protein kinase C activation in A10 cells. 27 Because HSP27 is involved in contraction of vascular smooth muscle cells 25,26 and intravenous anesthetics such as pentobarbital and propofol have blood pressure–lowering effects, 1–3 we thought it possible that the anesthesia by such agents might be associated with a reduction in HSP27 in vascular smooth muscle cells. In the present study, we investigated the effects of pentobarbital and propofol on the vasopressin-stimulated induction of HSP27 in A10 cells.
Materials and Methods
Materials
Arginine vasopressin was purchased from Peptide Institute Inc. (Minoh, Japan). Pentobarbital was purchased from Nacalai Tesque, Inc. (Tokyo, Japan). Propofol was purchased from Aldrich (Tokyo, Japan). 12-o  -tetradecanoylphorbol 13-acetate (TPA) was purchased from Sigma Chemical Co. (St. Louis, MO). HSP70 antibodies were purchased from Santa Cruz (Santa Cruz, CA). An ECL Western blotting detection system was obtained from Amersham Japan (Tokyo, Japan). Other materials and chemicals were obtained from commercial sources. Vasopressin and pentobarbital were dissolved in an assay buffer (consisting of 5 mm HEPES, pH 7.4; 150 mm NaCl; 5 mm KCl; 0.8 mm MgSO4; 1 mm CaCl2; and 5.5 mm glucose) containing 0.01% bovine serum albumin (BSA). We used the assay buffer containing 0.01% BSA as the vehicle control for pentobarbital. Propofol was dissolved in ethanol. The maximum concentration of ethanol in the culture medium was 0.1%, and this did not affect the immunoassay of HSP27. We used the assay buffer containing 0.01% BSA and 0.1% ethanol as the vehicle control for propofol.
Cell Culture
A10 cells derived from rat aortic smooth muscle cells 28 were obtained from the American Type Culture Collection (Rockville, MD). The cells (1 × 105) were seeded into 35- or 90-mm-diameter dishes and maintained at 37°C in a humidified atmosphere of 5% carbon dioxide and 95% air in 2 ml of Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum. After 5 days, the medium was exchanged for 2 ml of serum-free Dulbecco’s modified Eagle’s medium. The cells were used for experiments 48 h later. The cells were treated with pentobarbital or propofol in serum-free Dulbecco’s modified Eagle’s medium for the indicated periods.
Western Blot Analysis of HSP70 and HSP27
Cultured cells were stimulated by vasopressin for 48 h. The stimulated cells were rinsed twice with the assay buffer, lysed, homogenized and sonicated in a lysis buffer containing 62.5 mm Tris/Cl, pH 6.8, 2% sodium dodecyl sulfate, 50 mm dithiothreitol, and 10% glycerol. The cytosolic fraction was collected as the supernatant after centrifugation at 125,000 g  for 10 min at 4°C. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis was performed by the method of Laemmli 29 in 10% polyacrylamide gel. Western blotting analysis was performed as described previously 19,20 using HSP70 antibodies or HSP27 antibodies, with peroxidase-labeled antibodies raised in goat against rabbit immunoglobulin G being used as second antibodies. Peroxidase activity on the nitrocellulose sheet was visualized on x-ray film by means of the ECL Western blotting detection system.
Immunoassay of HSP27
The concentrations of HSP27 in soluble extracts of the cells were determined by means of a sandwich-type enzyme immunoassay, as described previously. 27 Cultured cells were pretreated with pentobarbital (0.1–0.8 mm), propofol (1 μm to 0.1 mm), or vehicle and then stimulated by vasopressin (0.1 μm) or TPA (0.1 μm) for the indicated periods in 1 ml of serum-free Dulbecco’s modified Eagle’s medium. The stimulated cells were washed twice with 1 ml of phosphate-buffered saline and frozen at −80°C for a few days before analysis. The frozen cells on each dish were collected and suspended in 0.3 ml of phosphate-buffered saline, then each suspension was sonicated and centrifuged at 125,000 g  for 20 min at 4°C. The supernatant was used for the immunoassay of HSP27. In brief, we used an enzyme immunoassay system that employs polystyrene balls (3.2 mm in diameter; Immuno Chemicals, Okayama, Japan) carrying immobilized F(ab′)2 fragments of antibody and the same Fab′ fragments labeled with β-d-galactosidase from Escherichia coli  . A polystyrene ball carrying antibodies was incubated either with the purified standard for HSP27 or with an aliquot of the samples. This incubation was conducted at 30°C for 5 h in a final volume of 0.5 ml of 10 mm sodium phosphate buffer, pH 7.0, containing 0.3 m NaCl, 0.5% hydrolyzed gelatin, 0.1% BSA, 1 mm MgCl2and 0.1% NaN3. After washing, each ball was incubated at 4°C overnight with 1.5 mU of galactosidase-labeled antibodies in a volume of 0.2 ml with 10 mm sodium phosphate buffer, pH 7.0, containing 0.1 m NaCl, 1 mm MgCl2, 0.1% BSA, and 0.1% NaN3. The galactosidase activity bound to the ball was assayed using a fluorogenic substrate, 4-methylumbelliferyl-β-d-galactoside.
Isolation of RNA and Northern Blot Analysis of mRNA for HSP27
Cultured cells were pretreated with pentobarbital (0.8 mm) for 20 min and then stimulated by vasopressin (0.1 μm) in 1 ml of serum-free Dulbecco’s modified Eagle’s medium. After 12 h, the stimulated cells were washed twice with 1 ml of phosphate-buffered saline and frozen at −80°C for a few days before analysis. Total RNA was isolated using a QuickPrep Total RNA Extraction kit (Pharmacia Biotech, Tokyo, Japan). Twenty micrograms of total RNA was then subjected to electrophoresis on a 0.9% agarose/2.2 m formaldehyde gel and blotted onto a nitrocellulose membrane. For Northern blot, the membrane was allowed to hybridize with a cDNA probe that had been labeled using a Multiprime DNA labeling system (Amersham, Buckinghamshire, United Kingdom), as described previously. 30 A Bam  HI-Hind  III fragment of cDNA for mouse HSP27 was provided by Dr. L. F. Cooper of the University of North Carolina. 31 
Other Methods
Protein concentrations in soluble extracts were determined using a protein assay kit (Bio-Rad, Hercules, CA), with BSA as the standard protein. Rat HSP27, which was used as the standard for the immunoassay, was purified from skeletal muscle. 19,20 
Statistical Analysis
The data were analyzed by analysis of variance followed by the Student-Newman-Keuls test. P  values < 0.05 were considered significant. All data are presented as the mean ± SD of triplicate determinations.
Results
Effects of Vasopressin on the Induction of HSP70 and HSP27
Vasopressin had little effect on the levels of HSP70 in vascular smooth muscle A10 cells while increasing the levels of HSP27 in the same sample (fig. 1).
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
×
Effects of Pentobarbital and Propofol on the Vasopressin-induced Accumulation of HSP27
Pentobarbital (0.4 mm), which by itself had little effect on the basal levels of HSP27, significantly (time-dependently up to 48 h) inhibited the HSP27 accumulation induced by vasopressin (0.1 μm;fig. 2A). On the contrary, propofol (0.1 mm) did not affect the vasopressin-stimulated accumulation of HSP27 up to 48 h (data not shown). The inhibitory effect of pentobarbital on the HSP27 accumulation was dose-dependent (0.1–0.8 mm), and it was significant at doses of 0.2 mm or more (fig. 2B). In contrast, propofol had little effect on the HSP27 accumulation induced by vasopressin over the range 1 μm to 0.1 mm (fig. 3). Long-term treatment (48 or 96 h) with pentobarbital did not affect the basal levels of HSP27 (table 1). In addition, pentobarbital reduced the vasopressin-stimulated HSP27 accumulation regardless of whether the cells had or had not been pretreated with pentobarbital (table 1).
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A  ) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B  ) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with vasopressin alone.
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A 
	) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B 
	) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P 
	< 0.05 compared with vasopressin alone.
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A  ) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B  ) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with vasopressin alone.
×
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
×
Table 1. Effect of Pretreatment with Pentobarbital on the Accumulation of HSP27 by Vasopressin in A10 Cells
Image not available
Table 1. Effect of Pretreatment with Pentobarbital on the Accumulation of HSP27 by Vasopressin in A10 Cells
×
Effect of Pentobarbital on the Vasopressin-stimulated Levels of mRNA for HSP27
We previously showed that vasopressin stimulates the expression levels of mRNA for HSP27. 27 We next examined the effect of pentobarbital on the levels of mRNA for HSP27 induced by vasopressin. Pentobarbital (0.8 mm), which alone did not affect the basal levels, significantly reduced the vasopressin (0.1 μm)-stimulated levels of mRNA for HSP27 (fig. 4).
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
×
Effects of Pentobarbital and Propofol on the TPA-induced Accumulation of HSP27
We previously reported that TPA alone, an activator of protein kinase C, 32 significantly stimulates HSP27 induction in A10 cells and that vasopressin stimulates the induction of HSP27 through protein kinase C activation. 27 Pentobarbital markedly inhibited the HSP27 accumulation induced by TPA (0.1 μm;fig. 5). This inhibitory effect of pentobarbital on the HSP27 accumulation was dose-dependent (0.1–0.8 mm), and it was significant at doses of 0.1 mm or more (fig. 5). In contrast, propofol (0.1 mm) had no such effect (284 ± 18 ng/mg protein for vehicle; 900 ± 144 ng/mg protein for 0.1 μm TPA; 312 ± 46 ng/mg protein for 0.1 mm propofol; 961 ± 228 ng/mg protein for 0.1 μm TPA with 0.1 mm propofol, as measured during a stimulation of 48 h).
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with TPA alone.
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P 
	< 0.05 compared with TPA alone.
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with TPA alone.
×
Discussion
We previously showed that in an aortic smooth muscle cell line, A10 cells, vasopressin stimulates the induction of HSP27. 27 In the present study, we examined the effects of pentobarbital and propofol on the HSP27 induction stimulated by vasopressin in these cells. Pentobarbital significantly reduced the vasopressin-induced accumulation of HSP27 in a time- and dose-dependent fashion. In contrast, propofol had no such effect. In addition, we demonstrated that pentobarbital suppressed the vasopressin-stimulated expression levels of mRNA for HSP27. Thus, our findings suggest that pentobarbital, but not propofol, inhibits the vasopressin-stimulated HSP27 induction in aortic smooth muscle cells.
High-molecular-weight HSPs such as HSP70 are well known to act as molecular chaperones. 14 It is recognized that low-molecular-weight HSPs such as HSP27 may also act as chaperones. 14,21 It has been shown that heat stress induces both HSP70 and HSP27 in vascular smooth muscle cells. 14 In addition, an expression of HSP27 is reportedly induced in aortic smooth muscle cells in restrained rats. 14 In our study, vasopressin did not affect the levels of HSP70, but it did stimulate the levels of HSP27 in A10 cells. As for the roles played by HSP27 in the vascular system, it has recently been reported that thrombin and serotonin induce contraction of vascular smooth muscle, and that the contraction is associated with an increased phosphorylation of HSP27. 25,26 These findings lead us to speculate that HSP27 may have important effects on aortic smooth muscle cell functions after stimulation by vasoactive agents. It is well recognized that the administration of pentobarbital or propofol reduces systemic blood pressure. 2,3 These anesthetics have direct and indirect effects on the cardiovascular system. 2,3 As for the direct effect on the cardiovascular system, it has been shown that they reduce the systemic vascular resistance through affecting vascular smooth muscle cells. 2,3,33,34 Investigations of HSPs, especially HSP27, in vascular smooth muscle cells suggest that HSP27 may contribute to physiologic and pathologic processes such as contraction, atherosclerosis, and aging of the vasculature. 14 In addition, intravenous anesthetics are administered to patients suffering from various stresses and complications. Consequently, further investigations of the relationship between intravenous anesthetics and HSPs in vascular smooth muscle cells could make an important contribution to clarify the exact mechanism underlying the effects of these agents on the vascular system.
In the present study, we showed that pentobarbital also reduced the TPA-induced accumulation of HSP27. We previously reported that TPA alone significantly stimulates HSP27 induction in A10 cells and that protein kinase C activation is involved in the vasopressin-stimulated induction of HSP27. 27 Therefore, it is probable that the inhibitory effect of pentobarbital is exerted at a point downstream from protein kinase C in these cells. On the other hand, in the present study, propofol did not affect the accumulation of HSP27 induced by vasopressin or TPA. We have reported that in A10 cells, propofol inhibits protein kinase C activation through a suppression of the activation of both phosphatidylinositol-hydrolyzing phospholipase C and phosphatidylcholine-hydrolyzing phospholipase D by endothelin-1 and vasopressin. 35,36 Clinically, propofol decreases systemic blood pressure after a bolus injection. 3 However, systemic blood pressure remains stable at the lower level during continuous infusion. 37,38 Therefore, it is conceivable that propofol inhibits short-acting signaling by vasoactive agents, resulting in a more-or-less immediate suppression of systemic blood pressure, but does not affect long-acting signaling, such as the induction of HSP27 seen in aortic smooth muscle cells.
Pentobarbital is used to control intracranial pressure, with serum concentrations reported to reach as high as 0.45 mm during a 4-mg · kg−1· h−1continuous infusion. 1 It has been shown that the protein binding of pentobarbital is 60%. 39 Thus, the free concentration of pentobarbital could reach 0.18 mm. If this is so, it is probable that a suppression of the induction of HSP27 by pentobarbital would occur in vascular smooth muscle cells at the doses used clinically. On the other hand, the plasma concentration of propofol has been reported to be 56–190 μm in patients in whom general anesthesia is maintained with continuous intravenous infusion of propofol alone. 40 It has been shown that approximately 97% of propofol is bound to plasma proteins. 41 Thus, free concentration of propofol is estimated to be 2–6 μm. In the current study, propofol had no effect on the vasopressin-stimulated HSP27 induction over the range 1 μm to 0.1 mm. Therefore, it is possible that propofol dose not affect on the induction of HSP27 stimulated by vasopressin, not only at doses use clinically, but also at the doses over clinical concentration.
In conclusion, these results suggest that pentobarbital suppresses the vasopressin-stimulated HSP27 induction in vascular smooth muscle cells. This inhibitory effect is probably exerted at a point downstream from protein kinase C.
The authors thank Kouseki Hirade and Hidenori Ito for skillful technical assistance.
References
Woodcock J, Ropper AH, Kennedy SK: High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome. Stroke 1982; 13:785–7Woodcock, J Ropper, AH Kennedy, SK
Piatt JH, Schiff SJ: High dose barbiturate therapy in neurosurgery and intensive care. Neurosurgery 1984; 15:427–44Piatt, JH Schiff, SJ
Sebel PS, Lowdon JD: Propofol: A new intravenous anesthetic. A nesthesiology 1989; 71:260–77Sebel, PS Lowdon, JD
Cook DJ, Housmans PR: Mechanism of the negative inotropic effect of propofol in isolated ferret ventricular myocardium. A nesthesiology 1994; 80:859–71Cook, DJ Housmans, PR
Gelissen HPMM, Epema AH, Henning RH, Krijnen HJ, Hennis PJ, den Hertog A: Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. A nesthesiology 1996; 84:397–403Gelissen, HPMM Epema, AH Henning, RH Krijnen, HJ Hennis, PJ den Hertog, A
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362:801–9Ross, R
Xuan Y-T, Su Y-F, Chang K-J, Watkins WD: A pertussis/cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell. Biochem Biophys Res Commun 1987; 146:898–906Xuan, Y-T Su, Y-F Chang, K-J Watkins, WD
Plevin R, Stewart A, Paul A, Wakelam MJO: Vasopressin-stimulated [3H]-inositol phosphate and [3H]-phosphatidylbutanol accumulation in A10 vascular smooth muscle cells. Br J Pharmacol 1992; 107:109–15Plevin, R Stewart, A Paul, A Wakelam, MJO
Miwa M, Kozawa O, Suzuki A, Watanabe Y, Shinoda J, Oiso Y: Vasopressin activates phospholipase D through pertussis toxin-insensitive GTP-binding protein in aortic smooth muscle cells: Function of Ca2+/calmodulin. Biochem Cell Biol 1995; 73:191–9Miwa, M Kozawa, O Suzuki, A Watanabe, Y Shinoda, J Oiso, Y
Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607–14Nishizuka, Y
Caramelo C, Okada K, Tsai P, Schrier RW: Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation. Am J Physiol 1989; 256:F875–81Caramelo, C Okada, K Tsai, P Schrier, RW
Nover L: Inducers of hsp synthesis: Heat shock and chemical stressors, Heat Shock Response. Edited by Nover L. Boca Raton, CRC Press, 1991, pp 5–40
Nover L, Scharf K-D: Heat shock proteins, Heat Shock Response. Edited by Nover L. Boca Raton, CRC Press, 1991, pp 41–128
Benjamin IJ, McMillan DR: Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease. Circ Res 1998; 83:117–32Benjamin, IJ McMillan, DR
Ellis RJ, van der Vies SM: Molecular chaperones. Annu Rev Biochem 1991; 60:321–47Ellis, RJ van der Vies, SM
Gething MJ, Sambrook J: Protein folding in the cell. Nature 1992; 355:22–44Gething, MJ Sambrook, J
Ingolia TD, Craig EA: Four small Drosophilia  heat shock proteins are related to each other and to mammalian α-crystallin. Proc Natl Acad Sci USA 1982; 79:2360–4Ingolia, TD Craig, EA
Hickey E, Brandon SE, Potter R, Stein J, Weber LA: Sequence and organization of genes encoding the human 27 kDa heat shock protein. Nucleic Acids Res 1986; 14:4127–45Hickey, E Brandon, SE Potter, R Stein, J Weber, LA
Kato K, Shinohara H, Kurobe N, Inaguma Y, Shimizu K, Ohshima K: Tissue distribution and developmental profiles of immunoreactive αB crystallin in the rat determined with a sensitive immunoassay system. Biochim Biophys Acta 1991; 1074:201–8Kato, K Shinohara, H Kurobe, N Inaguma, Y Shimizu, K Ohshima, K
Inaguma Y, Goto S, Shinohara H, Hasegawa K, Ohshima K, Kato K: Physiological and pathological changes in levels of the two small stress proteins, HSP27 and αB crystallin, in rat hindlimb muscles. J Biochem 1993; 114:378–84Inaguma, Y Goto, S Shinohara, H Hasegawa, K Ohshima, K Kato, K
Jakob U, Gaestel M, Engel K, Buchner J: Small heat shock proteins are molecular chaperones. J Biol Chem 1993; 268:1517–20Jakob, U Gaestel, M Engel, K Buchner, J
Kindas-Mugge I, Herbacek I, Jantschitsch C, Micksche M, Trautinger F: Modification of growth and tumorigenicity in epidermal cell lines by DNA-mediated gene transfer of M(r) 27,000 heat shock protein (hsp27). Cell Growth Differ 1996; 7:1167–74Kindas-Mugge, I Herbacek, I Jantschitsch, C Micksche, M Trautinger, F
Mehlen P, Schulze-Osthoff K, Arrigo AP: Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. J Biol Chem 1996; 271:16510–4Mehlen, P Schulze-Osthoff, K Arrigo, AP
Zhu Y, O’neill S, Saklatvala J, Tassi L, Mendelsohn ME: Phosphorylated HSP27 associates with the activation-dependent cytoskeleton in human platelets. Blood 1994; 84:3715–23Zhu, Y O’neill, S Saklatvala, J Tassi, L Mendelsohn, ME
Brophy CM, Beall A, Lamb S, Dickinson M, Ware DJ: Small heat shock proteins and vasospasm in human umbilical artery smooth muscle. Biol Reprod 1997; 57:1354–9Brophy, CM Beall, A Lamb, S Dickinson, M Ware, DJ
Brophy CM, Woodrum D, Dickinson M, Beall A: Thrombin activates MAPKAP2 kinase in vascular smooth muscle. J Vasc Surg 1998; 27:963–9Brophy, CM Woodrum, D Dickinson, M Beall, A
Kaida T, Kozawa O, Ito T, Tanabe K, Ito H, Matsuno H, Niwa M, Miyata, H, Uematsu T, Kato K: Vasopressin stimulates the induction of heat shock protein 27 and αB-crystallin via protein kinase C activation in vascular smooth muscle cells. Exp Cell Res 1999; 246:327–37Kaida, T Kozawa, O Ito, T Tanabe, K Ito, H Matsuno, H Niwa, M Miyata, H Uematsu, T Kato, K
Kimes BW, Brandt BL: Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 1976; 98:349–66Kimes, BW Brandt, BL
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–5Laemmli, UK
Kozawa O, Tanabe K, Ito H, Matsuno H, Niwa M, Kato K, Uematsu T: Sphingosine 1-phosphate regulates heat shock protein 27 induction by a p38 MAP kinase-dependent mechanism in aortic smooth muscle cells. Exp Cell Res 1999; 250:376–80Kozawa, O Tanabe, K Ito, H Matsuno, H Niwa, M Kato, K Uematsu, T
Cooper LF, Uoshima K: Differential estrogenic regulation of small Mr heat shock protein expression in osteoblasts. J Biol Chem 1994; 114:7869–73Cooper, LF Uoshima, K
Nishizuka Y: Studies and perspectives of protein kinase C. Science 1986; 233:305–12Nishizuka, Y
Moriyama S, Nakamura K, Hatano Y, Harioka T, Mori K: Responses to barbiturates of isolated dog cerebral and mesenteric arteries contracted with KCl and prostaglandin F2α. Acta Anesthesiol Scand 1990; 34:523–9Moriyama, S Nakamura, K Hatano, Y Harioka, T Mori, K
Imura N, Shiraishi Y, Katsuya H, Itoh T: Effect of propofol on norepinephrine-induced increass in [Ca2+]i and force in smooth muscle of the rabbit mesenteric resistance artery. A nesthesiology 1998; 88:1566–78Imura, N Shiraishi, Y Katsuya, H Itoh, T
Tanabe K, Kozawa O, Kaida T, Matsuno H, Niwa M, Ohta S, Dohi S, Uematsu T: Inhibitory effects of propofol on intracellular signaling by endothelin-1 in aortic smooth muscle cells. A nesthesiology 1998; 88:452–60Tanabe, K Kozawa, O Kaida, T Matsuno, H Niwa, M Ohta, S Dohi, S Uematsu, T
Tanabe K, Kozawa O, Matsuno H, Niwa M, Dohi S, Uematsu T: Effect of propofol on arachidonate cascade by vasopressin in aortic smooth muscle cells: Inhibition of PGI2synthesis. A nesthesiology 1999; 90:215–24Tanabe, K Kozawa, O Matsuno, H Niwa, M Dohi, S Uematsu, T
Doze van A, Shafer A, White PF: Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. A nesthesiology 1988; 69:63–71Doze van, A Shafer, A White, PF
McMurray TJ, Collier PS, Carson IW, Lyons SM, Elliott P: Propofol sedation after open heart surgery a clinical and pharmacokinetic study. Anesthesia 1990; 45:322–6McMurray, TJ Collier, PS Carson, IW Lyons, SM Elliott, P
Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607–14Franks, NP Lieb, WR
Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith R, Canada AT, Glass PSA: The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. A nesthesiology 1994; 81:820–8Smith, C McEwan, AI Jhaveri, R Wilkinson, M Goodman, D Smith, R Canada, AT Glass, PSA
Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R: Pharmacokinetics and protein binding of propofol in patients with cirrhosis. A nesthesiology 1988; 69:887–91Servin, F Desmonts, JM Haberer, JP Cockshott, ID Plummer, GF Farinotti, R
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
Fig. 1. Effect of vasopressin (AVP) on levels of HSP70 and HSP27 in A10 cells. Cultured cells were exposed to 0.1 μm of AVP or vehicle for 48 h. Cell lysates were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blot analysis using antibodies against HSP70 or HSP27.
×
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A  ) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B  ) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with vasopressin alone.
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A 
	) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B 
	) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P 
	< 0.05 compared with vasopressin alone.
Fig. 2. Effect of pentobarbital on vasopressin-induced accumulation of HSP27 in A10 cells. (A  ) Time course of the accumulation of HSP27 during the incubation period after vasopressin stimulation. Cultured cells were pretreated with 0.4 mm pentobarbital (closed symbols) or vehicle (open symbols) for 20 min, then exposed to 0.1 μm of vasopressin (circles) or vehicle (triangles) for the indicated periods. (B  ) Dose-dependent effect of pentobarbital on the accumulation of HSP27. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with vasopressin alone.
×
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
Fig. 3. Effect of propofol on vasopressin-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of propofol for 20 min, then exposed to 0.1 μm vasopressin (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations.
×
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
Fig. 4. Effect of pentobarbital on vasopressin (AVP)-stimulated levels of mRNA for HSP27 in A10 cells. Cultured cells were pretreated with 0.8 mm of pentobarbital or vehicle for 20 min, then exposed to 0.1 μm of AVP or vehicle for 12 h. The cells were collected, and total RNA was isolated. Twenty micrograms of RNA from each sample was subjected to electrophoresis and blotted onto a nitrocellulose membrane. The membrane was then allowed to hybridize with the cDNA probe for HSP27. Bands of 28S are shown for reference.
×
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with TPA alone.
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P 
	< 0.05 compared with TPA alone.
Fig. 5. Effect of pentobarbital on TPA-induced accumulation of HSP27 in A10 cells. Cultured cells were pretreated with various doses of pentobarbital for 20 min, then exposed to 0.1 μm TPA (closed circles) or vehicle (open circles) for 48 h. The concentrations of HSP27 in cell extracts were determined by a specific immunoassay. Each value represents the mean ± SD of triplicate determinations. Similar results were obtained with two other cell preparations. *P  < 0.05 compared with TPA alone.
×
Table 1. Effect of Pretreatment with Pentobarbital on the Accumulation of HSP27 by Vasopressin in A10 Cells
Image not available
Table 1. Effect of Pretreatment with Pentobarbital on the Accumulation of HSP27 by Vasopressin in A10 Cells
×